Cover	189	115

	Articles
95	Cover Article: Problem-Oriented Diagnosis Diagnostic Evaluation of Erectile Dysfunction THOMAS A. MILLER, CAPT, MC, USN A thorough history, focused physical examination and limited laboratory testing will provide the primary care physician with the information necessary to appropriately manage most patients with erectile dysfunction.
	Patient information: "Erectile Dysfunction," p. 109
115	Anticipatory Guidance in Infant Oral Health: Rationale and Recommendations OLGA M. SANCHEZ, D.M.D., M.S., and NOEL K. CHILDERS, D.D.S., M.S., PH.D. Early application of preventive measures may reduce or even eliminate dental disease. The American Academy of Pediatric Dentistry recommends that infants be scheduled for an initial oral evaluation within six months of the eruption of the first primary tooth but by no later than 12 months of age.
	Patient information: "Taking Care of Your Child's Teeth," p. 123
129	Cardiovascular Medicine Update Contemporary Management of Angina: Part II. Medical Management of Chronic Stable Angina DIANE R. ZANGER, M.D., ALLEN J. SOLOMON, M.D., and BERNARD J. GERSH, M.B., CH.B., D.PHIL. Knowing how and when to use nitrates, beta blockers, calcium channel blockers, aspirin and cholesterol-lowering agents holds the key to the management of chronic stable angina.
141	The Older Adult Driver DAVID B. CARR, M.D. Many disorders that impair driving ability in older adults can be detected and treated by family physicians. When driving cessation is recommended, counseling is essential.
	Patient information: "Driving Skills in Older Adults," p. 148
151	Osteochondritis Dissecans: A Diagnosis Not to Miss ALLEN L. HIXON, M.D., and LISA M. GIBBS, M.D. Clinical findings are often subtle in patients with osteochondritis dissecans, so diagnosis of this condition requires a high index of suspicion.
	Patient information: "What Should I Know About Osteochondritis Dissecans?" p. 158
163	1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part I. Prevention of Exposure U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE, CENTERS FOR DISEASE CONTROL AND PREVENTION This is part I of a three-part series of articles derived from the USPHS/IDSA guidelines. New data about the prevention of opportunistic diseases have emerged since the guidelines were first published in 1997, and the first part of this series will discuss prevention of exposure.
180	Clinical Pharmacology Newer Intranasal Migraine Medications CRAIG D. LOGEMANN, PHARM.D., and LYNN M. RANKIN, M.D. Two new intranasal migraine medications may offer specific advantages for patients who are seeking alternatives to various oral or parenteral migraine abortive therapies.

Cover Illustration © 2000 William B. Westwood, Albany, N.Y.
Copyright © 2000 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.